GSK-3β inhibitor suppresses symptom onset and progression of ALS model mice

被引：0
|
作者：
Koh, Seong-Ho
yu, Hn-Jeung Yu
Kim, Juhan
Kim, Hyun
机构：
[1] Hanyang Univ, Coll Med, Dept Neurol, Seoul 133791, South Korea
[2] Bundang Jesaeng Hosp, Dept Neurol, Songnam, Kyunggi, South Korea
来源：
NEUROMUSCULAR DISORDERS | 2006年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [1] GSK-3 inhibitor suppresses symptom onset and progression of ALS model mice.
    Koh, S. H.
    Yu, H. J.
    Han, K. S.
    Kim, H. Y.
    Lee, K. Y.
    Lee, Y. J.
    Kim, H. T.
    Kim, J.
    Kim, M. H.
    Kim, S. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 95 - 95
  • [2] The neuroprotective effect of the GSK-3β inhibitor and influence on the extrinsic apoptosis in the ALS transgenic mice
    Ahn, Suk-Won
    Kim, Jee-Eun
    Park, Kyung Seok
    Choi, Won-Jun
    Hong, Yoon-Ho
    Kim, Sung-Min
    Kim, Seung Hyun
    Lee, Kwang-Woo
    Sung, Jung-Joon
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2012, 320 (1-2) : 1 - 5
  • [3] NEUROPROTECTION OF GSK-3β INHIBITOR IN TRANSGENIC SOD1-G93A MICE OF ALS
    Ahn, S-W
    Sung, J-J
    Hong, Y-H
    Kim, J-E
    Yang, J-W
    Park, S-Y
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 (02) : 93 - 93
  • [4] Dual Inhibitor of HDAC and GSK-3β Prevents Pancreatic Cancer Progression
    Chheda, C.
    Soufi, B.
    Fall, C.
    Hu, R.
    Laayouni, M.
    Murali, R.
    Pandol, S. J.
    Edderkaoui, M.
    PANCREAS, 2015, 44 (08) : 1366 - 1366
  • [5] Glycogen synthase kinase-3 inhibitor suppresses disease onset and prolongs life span of ALS model mice
    Kim, S. H.
    Yoo, H. J.
    Koh, S. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 285 - 285
  • [6] Intrathecal delivery of HGF from the ALS onset suppresses disease progression in a rat ALS model
    Aoki, Masashi
    Warita, Hitoshi
    Itoyama, Yasuto
    NEUROSCIENCE RESEARCH, 2008, 61 : S15 - S15
  • [7] Isoorientin, a GSK-3β inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice
    Tan, Xiaoqin
    Liang, Zhibin
    Li, Yingui
    Zhi, Yingkun
    Yi, Lang
    Bai, Shasha
    Forest, Kelly H.
    Nichols, Robert A.
    Dong, Yan
    Li, Qing X.
    BEHAVIOURAL BRAIN RESEARCH, 2021, 398
  • [8] Novel GSK-3 kinase inhibitor Pym-5 induces GSK-3β rather than GSK-3α-dependent melanogenesis in murine melanoma cells
    Jia, Qi
    Tao, Li
    Zhou, Yinyin
    Song, Li
    Wei, Zhonghong
    Lu, Tao
    Woodgett, James R.
    Lu, Yin
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2022, 106 (03) : 170 - 180
  • [9] Genistein suppresses the inflammation and GSK-3 pathway in an animal model of spontaneous ovarian cancer
    Erten, Fusun
    Yenice, Engin
    Orhan, Cemal
    Besir, E. R.
    Demirel Oner, Pinar
    Defo Deeh, Patrick Brice
    Sahin, Kazim
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (03) : 1465 - 1471
  • [10] Activator or inhibitor? GSK-3 as a new drug target
    Takahashi-Yanaga, Fumi
    BIOCHEMICAL PHARMACOLOGY, 2013, 86 (02) : 191 - 199
12345